Bed Bath & Beyond Expects $40M Cost Savings
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 28 2026
0mins
Should l Buy BBBY?
Source: stocktwits
- Annual Cost Savings: Wedbush anticipates that Bed Bath & Beyond will achieve at least $40 million in annual cost savings and efficiency gains within the next 12 to 18 months, which will significantly improve the company's financial health and enhance its competitive position in the market.
- Sales Growth Recovery: The company reported first-quarter revenue of $248 million, marking a nearly 7% year-over-year increase and its first quarterly sales growth in nearly five years, indicating the initial success of its restructuring plan and boosting investor confidence.
- Strong Stock Performance: Bed Bath & Beyond shares rose 5% in Tuesday trading, breaching the 200-day moving average for the first time in over three months, reflecting strong bullish sentiment in the market regarding its turnaround story, despite an early gain exceeding 30%.
- Reduced Operating Expenses: The company's operating expenses have dropped to their lowest level in a decade, with CEO Marcus Lemonis emphasizing that streamlining operations and cutting unnecessary costs have significantly improved customer acquisition efficiency, further enhancing the company's profitability.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BBBY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BBBY
Wall Street analysts forecast BBBY stock price to rise
5 Analyst Rating
1 Buy
4 Hold
0 Sell
Hold
Current: 5.360
Low
8.00
Averages
11.67
High
17.00
Current: 5.360
Low
8.00
Averages
11.67
High
17.00
About BBBY
Bed Bath & Beyond, Inc. is an e-commerce-focused retailer with an affinity model that owns or has ownership interests in various retail brands. The Company is building an Everything Home company through an integrated platform across omnichannel retail, home services, and products and services. The Company's brands include Bed Bath & Beyond, buybuy BABY, Overstock, and Kirkland’s. It also invests in and operates differentiated blockchain and data infrastructure, including tZERO and GrainChain, which enhance transparency, efficiency, and liquidity across financial services, supply chains, and real-world assets. Together, its retail brands, digital platforms, financial and protection services, and technology investments form a connected system designed to advocate for consumers. Through its Bed Bath & Beyond brand, it provides an extensive array of home-related products. Through its Overstock brand, it provides an array of goods at discounted prices. It also owns the Tokens.com domain.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Amplify Investment Increases Stake in Bed Bath & Beyond to 8.7%
- Passive Stake Disclosure: Amplify Investment disclosed a passive stake of 8.7% in Bed Bath & Beyond, amounting to 6,039,111 shares, which is a 4.2% increase from the last ownership disclosure, indicating sustained confidence in the company.
- SEC Disclosure Impact: The ownership exceeding 5% triggers SEC beneficial ownership disclosure, making Amplify's significant investment in Bed Bath & Beyond visible to the market, which could support the company's potential turnaround.
- Stock Price Context: Despite Bed Bath & Beyond trading at the lower end of its 52-week range ($3.74 to $12.65), analysts have noted signs of a turnaround under CEO Marcus Lemonis, although achieving positive adjusted EBITDA remains a work in progress.
- Short Interest Situation: Currently, short interest in Bed Bath & Beyond stands at 12.3% of the total float, indicating mixed market sentiment regarding its future performance, despite signs of the company striving for profitability.
See More
Tech Stocks Decline Following OpenAI Misses
- Oracle Stock Drop: Oracle's shares fell over 3% after OpenAI missed its user and revenue targets, raising concerns about the sustainability of AI spending and impacting its $300 billion five-year partnership with OpenAI.
- Chip Stocks Decline: Following the OpenAI news, Nvidia and AMD saw declines of over 3% and 4%, respectively, while Arm Holdings plummeted more than 8%, indicating a waning market confidence in AI infrastructure.
- Centene Guidance Raise: Centene's shares surged 12% after it raised its full-year adjusted EPS guidance to over $3.40, surpassing the market consensus of $3.02, reflecting strong performance in the health insurance sector.
- Erasca Stock Plunge: Erasca's stock cratered nearly 50% after reporting a patient death in an early-stage trial, despite analysts viewing the incident as isolated, highlighting investor sensitivity to risks in the biotech sector.
See More
Bed Bath & Beyond Expects $40M Cost Savings
- Annual Cost Savings: Wedbush anticipates that Bed Bath & Beyond will achieve at least $40 million in annual cost savings and efficiency gains within the next 12 to 18 months, which will significantly improve the company's financial health and enhance its competitive position in the market.
- Sales Growth Recovery: The company reported first-quarter revenue of $248 million, marking a nearly 7% year-over-year increase and its first quarterly sales growth in nearly five years, indicating the initial success of its restructuring plan and boosting investor confidence.
- Strong Stock Performance: Bed Bath & Beyond shares rose 5% in Tuesday trading, breaching the 200-day moving average for the first time in over three months, reflecting strong bullish sentiment in the market regarding its turnaround story, despite an early gain exceeding 30%.
- Reduced Operating Expenses: The company's operating expenses have dropped to their lowest level in a decade, with CEO Marcus Lemonis emphasizing that streamlining operations and cutting unnecessary costs have significantly improved customer acquisition efficiency, further enhancing the company's profitability.
See More
NASDAQ 100 Pre-Market Activity Overview
- Market Decline: The NASDAQ 100 pre-market indicator fell by 350.87 points to 26,954.81, indicating a bearish market sentiment that could impact investor confidence and subsequent trading decisions.
- NVIDIA Trading Activity: NVIDIA Corporation (NVDA) saw a drop of $7.56 to $209.05 with a trading volume of 10,044,906 shares, reflecting potential profit-taking after reaching a 52-week high in the previous session.
- ProShares UltraPro QQQ Performance: ProShares UltraPro QQQ (TQQQ) decreased by $2.66 to $59.98, with a volume of 7,002,488 shares, representing a 138.39% increase from its 52-week low, indicating strong market rebound interest in this ETF.
- Pfizer Earnings Expectations: Pfizer, Inc. (PFE) rose by $0.825 to $27.62 with a trading volume of 3,297,418 shares, and is expected to report earnings of $0.74 per share for March 2026, reflecting a 92% increase from last year, showcasing the company's robust profitability.
See More
Bed Bath & Beyond Soars After Q1 Earnings Report
- Earnings Highlights: Bed Bath & Beyond (BBBY) reported a 6.9% year-over-year revenue increase in Q1, with a 9.4% rise excluding Canada, marking the first positive growth in over four years, indicating significant recovery progress.
- Analyst Ratings: Wedbush Securities reiterated an 'Outperform' rating on BBBY, with analyst Alicia Reese projecting at least $40 million in annual cost savings and productivity efficiencies within 12-18 months from integrating new home assets, reflecting strong confidence in growth.
- Cautious Outlook: Needham adopted a more cautious stance with a 'Hold' rating, as analyst Bernie McTernan noted that while revenue growth is promising, integration costs are a drag on 2026 EBITDA, highlighting ongoing challenges in the company's transformation.
- Market Reaction: BBBY shares surged 24.9% in premarket trading to $6.67, the highest level in over three months, reflecting investor optimism about the company's recovery prospects, while short interest stands at 11.4% of the total float.
See More
Mixed Earnings Reports from Major Companies
- General Motors Beats Expectations: General Motors reported adjusted earnings of $3.70 per share for Q1, significantly above the $2.62 expected by analysts, and raised its 2026 guidance, resulting in a stock price increase of over 5%.
- Coca-Cola's Strong Earnings: Coca-Cola's quarterly earnings of 86 cents per share and revenue of $12.47 billion exceeded analyst expectations, leading to a 2% stock price increase, indicating robust market demand and brand strength.
- Spotify's Weak Guidance: Spotify's first-quarter operating income guidance fell short of expectations, causing its stock to drop nearly 12%, despite revenue meeting forecasts, reflecting market concerns about its future growth prospects.
- Bed Bath & Beyond Soars: The company reported Q1 revenue of $247.8 million, surpassing the $240.1 million expected by analysts, resulting in a 25% stock price surge, showcasing its potential recovery in a competitive retail environment.
See More
Amplify Investment Increases Stake in Bed Bath & Beyond to 8.7%
- Passive Stake Disclosure: Amplify Investment disclosed a passive stake of 8.7% in Bed Bath & Beyond, amounting to 6,039,111 shares, which is a 4.2% increase from the last ownership disclosure, indicating sustained confidence in the company.
- SEC Disclosure Impact: The ownership exceeding 5% triggers SEC beneficial ownership disclosure, making Amplify's significant investment in Bed Bath & Beyond visible to the market, which could support the company's potential turnaround.
- Stock Price Context: Despite Bed Bath & Beyond trading at the lower end of its 52-week range ($3.74 to $12.65), analysts have noted signs of a turnaround under CEO Marcus Lemonis, although achieving positive adjusted EBITDA remains a work in progress.
- Short Interest Situation: Currently, short interest in Bed Bath & Beyond stands at 12.3% of the total float, indicating mixed market sentiment regarding its future performance, despite signs of the company striving for profitability.
See More
Tech Stocks Decline Following OpenAI Misses
- Oracle Stock Drop: Oracle's shares fell over 3% after OpenAI missed its user and revenue targets, raising concerns about the sustainability of AI spending and impacting its $300 billion five-year partnership with OpenAI.
- Chip Stocks Decline: Following the OpenAI news, Nvidia and AMD saw declines of over 3% and 4%, respectively, while Arm Holdings plummeted more than 8%, indicating a waning market confidence in AI infrastructure.
- Centene Guidance Raise: Centene's shares surged 12% after it raised its full-year adjusted EPS guidance to over $3.40, surpassing the market consensus of $3.02, reflecting strong performance in the health insurance sector.
- Erasca Stock Plunge: Erasca's stock cratered nearly 50% after reporting a patient death in an early-stage trial, despite analysts viewing the incident as isolated, highlighting investor sensitivity to risks in the biotech sector.
See More
Bed Bath & Beyond Expects $40M Cost Savings
- Annual Cost Savings: Wedbush anticipates that Bed Bath & Beyond will achieve at least $40 million in annual cost savings and efficiency gains within the next 12 to 18 months, which will significantly improve the company's financial health and enhance its competitive position in the market.
- Sales Growth Recovery: The company reported first-quarter revenue of $248 million, marking a nearly 7% year-over-year increase and its first quarterly sales growth in nearly five years, indicating the initial success of its restructuring plan and boosting investor confidence.
- Strong Stock Performance: Bed Bath & Beyond shares rose 5% in Tuesday trading, breaching the 200-day moving average for the first time in over three months, reflecting strong bullish sentiment in the market regarding its turnaround story, despite an early gain exceeding 30%.
- Reduced Operating Expenses: The company's operating expenses have dropped to their lowest level in a decade, with CEO Marcus Lemonis emphasizing that streamlining operations and cutting unnecessary costs have significantly improved customer acquisition efficiency, further enhancing the company's profitability.
See More
NASDAQ 100 Pre-Market Activity Overview
- Market Decline: The NASDAQ 100 pre-market indicator fell by 350.87 points to 26,954.81, indicating a bearish market sentiment that could impact investor confidence and subsequent trading decisions.
- NVIDIA Trading Activity: NVIDIA Corporation (NVDA) saw a drop of $7.56 to $209.05 with a trading volume of 10,044,906 shares, reflecting potential profit-taking after reaching a 52-week high in the previous session.
- ProShares UltraPro QQQ Performance: ProShares UltraPro QQQ (TQQQ) decreased by $2.66 to $59.98, with a volume of 7,002,488 shares, representing a 138.39% increase from its 52-week low, indicating strong market rebound interest in this ETF.
- Pfizer Earnings Expectations: Pfizer, Inc. (PFE) rose by $0.825 to $27.62 with a trading volume of 3,297,418 shares, and is expected to report earnings of $0.74 per share for March 2026, reflecting a 92% increase from last year, showcasing the company's robust profitability.
See More
Bed Bath & Beyond Soars After Q1 Earnings Report
- Earnings Highlights: Bed Bath & Beyond (BBBY) reported a 6.9% year-over-year revenue increase in Q1, with a 9.4% rise excluding Canada, marking the first positive growth in over four years, indicating significant recovery progress.
- Analyst Ratings: Wedbush Securities reiterated an 'Outperform' rating on BBBY, with analyst Alicia Reese projecting at least $40 million in annual cost savings and productivity efficiencies within 12-18 months from integrating new home assets, reflecting strong confidence in growth.
- Cautious Outlook: Needham adopted a more cautious stance with a 'Hold' rating, as analyst Bernie McTernan noted that while revenue growth is promising, integration costs are a drag on 2026 EBITDA, highlighting ongoing challenges in the company's transformation.
- Market Reaction: BBBY shares surged 24.9% in premarket trading to $6.67, the highest level in over three months, reflecting investor optimism about the company's recovery prospects, while short interest stands at 11.4% of the total float.
See More
Mixed Earnings Reports from Major Companies
- General Motors Beats Expectations: General Motors reported adjusted earnings of $3.70 per share for Q1, significantly above the $2.62 expected by analysts, and raised its 2026 guidance, resulting in a stock price increase of over 5%.
- Coca-Cola's Strong Earnings: Coca-Cola's quarterly earnings of 86 cents per share and revenue of $12.47 billion exceeded analyst expectations, leading to a 2% stock price increase, indicating robust market demand and brand strength.
- Spotify's Weak Guidance: Spotify's first-quarter operating income guidance fell short of expectations, causing its stock to drop nearly 12%, despite revenue meeting forecasts, reflecting market concerns about its future growth prospects.
- Bed Bath & Beyond Soars: The company reported Q1 revenue of $247.8 million, surpassing the $240.1 million expected by analysts, resulting in a 25% stock price surge, showcasing its potential recovery in a competitive retail environment.
See More
